✦ LIBER ✦

Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis

✍ Scribed by Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Mara Ghilardi; Sandro Barni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Panitumumab in Patients with KRAS Wild-T

✍ Wadlow, R. C.; Hezel, A. F.; Abrams, T. A.; Blaszkowsky, L. S.; Fuchs, C. S.; Ku 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 548 KB

Clinical outcome of panitumumab for meta

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 384 KB

No Survival Benefit from Adding Cetuxima

✍ Zhou, Si-wei; Huang, Yuan-yuan; Wei, Ying; Jiang, Zhi-min; Zhang, Yuan-dong; Yan 📂 Article 📅 2012 🏛 Public Library of Science 🌐 English ⚖ 533 KB

Predicting cetuximab accumulation in KRA

✍ Arifudin Achmad; Hirofumi Hanaoka; Hiroki Yoshioka; Shinji Yamamoto; Hideyuki To 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Economic analysis of bevacizumab, cetuxi

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB

Cost-Effectiveness of Cetuximab, Cetuxim

✍ Hoyle, Martin; Peters, Jaime; Crathorne, Louise; Jones-Hughes, Tracey; Cooper, C 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB